XML 36 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Leases
12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Leases
6.
Leases

The Company’s long-term property lease with Alexandria for its corporate headquarters in San Francisco, California, had an initial term of 15 years, scheduled to expire in 2023. The original lease was accounted for as a finance lease.
 

On June 1, 2021, the Company entered into an amendment with Alexandria to extend the lease to 2028 (“Lease Amendment”). Under the terms of the Lease Amendment, the Company has two optional rights to each extend the lease for an additional five years. The lease contract provides for a fixed annual rent, with scheduled increases of two percent that occur on each anniversary of the rent commencement date through 2023, and with scheduled increases of three percent that occur on each anniversary of the rent commencement date through 2028. This lease requires the Company to pay all costs of ownership, operation, and maintenance of the premises, including without limitation all operating costs, insurance costs, and taxes.

The Company determined that the Lease Amendment was a lease modification, effective June 1, 2021, and thus reassessed the lease classification, remeasured the related lease liability using an updated discount rate, and adjusted the related right-of-use asset under the lease modification guidance under the ASC 842. Accordingly, on June 1, 2021, the Company determined that the modified lease be accounted for as an operating lease, and therefore derecognized the previous finance lease right-of-use asset of $24.6 million and the related finance lease liability of $32.6 million, and recognized an operating lease right-of-use asset of $93.2 million and the related operating lease liability of $101.2 million. Starting June 1, 2021, the cash payment related to this lease was classified as an operating activity.

During the first quarter of 2021, after FibroGen Beijing’s previous long-term lease agreement expired, the Company entered into a new lease agreement with the landlord for the same pilot plant located in Beijing Yizhuang Biomedical Park of BDA. The new lease term is five year, scheduled to expire in 2026, and is treated as an operating lease. Accordingly, the Company recorded $3.4 million in the operating right-of-use assets and total operating lease liabilities, respectively. The lease contract provides for fixed quarterly rent payments, and requires the Company to pay operating and maintenance costs.

The Company currently has several additional real estate leases for office spaces in Shanghai and Beijing, China, which are treated as operating leases. These leases have lease terms ranging from one to five years, expiring in 2025. These lease contracts provide for fixed quarterly rent payments, and require the Company to pay operating and maintenance costs, and a fixed amount for property management fees.

In addition, the Company has several immaterial lease arrangements in China and U.S. for office equipment, scientific devices and automobile leases, with contracted lease terms ranging from one to five years, treated as finance leases or operating leases.

The Company’s lease assets and related lease liabilities were as follows (in thousands):

 

 

 

 

December 31,

 

 

Balance Sheet Line Item

 

2022

 

 

2021

 

Assets

 

 

 

 

 

 

 

Finance:

 

 

 

 

 

 

 

Right-of-use assets cost

 

 

$

2,367

 

 

$

2,165

 

Accumulated amortization

 

 

 

(1,932

)

 

 

(1,404

)

Finance lease right-of-use assets, net

Other assets

 

 

435

 

 

 

761

 

Operating:

 

 

 

 

 

 

 

Right-of-use assets cost

 

 

 

101,990

 

 

 

100,912

 

Accumulated amortization

 

 

 

(22,097

)

 

 

(9,800

)

Operating lease right-of-use assets, net

Operating lease right-of-use assets

 

 

79,893

 

 

 

91,112

 

Total lease assets

 

 

$

80,328

 

 

$

91,873

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Finance lease liabilities

Accrued and other current liabilities

 

$

36

 

 

$

11

 

Operating lease liabilities

Operating lease liabilities, current

 

 

10,292

 

 

 

10,944

 

Non-current:

 

 

 

 

 

 

 

Finance lease liabilities

Other long-term liabilities

 

 

137

 

 

 

3

 

Operating lease liabilities

Operating lease liabilities, non-current

 

 

79,593

 

 

 

88,776

 

Total lease liabilities

 

 

$

90,058

 

 

$

99,734

 

The components of lease expense were as follows (in thousands):

 

 

 

 

Years Ended December 31,

 

 

Statement of Operations Line Item

 

2022

 

 

2021

 

 

2020

 

Finance lease cost:

 

 

 

 

 

 

 

 

 

 

Amortization of
   right-of-use assets

Cost of goods sold;
Research and development;
Selling, general and administrative expenses

 

$

587

 

 

$

4,639

 

 

$

10,369

 

Interest on lease liabilities

Interest expense

 

 

 

 

 

628

 

 

 

1,932

 

Operating lease cost

Cost of goods sold;
Research and development;
Selling, general and administrative expenses

 

 

17,125

 

 

 

10,722

 

 

 

1,151

 

Sublease income

Selling, general and administrative expenses

 

 

(3,373

)

 

 

(1,271

)

 

 

(1,201

)

Total lease cost

 

 

$

14,339

 

 

$

14,718

 

 

$

12,251

 

 

Supplemental cash flow information related to leases were as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

 

 

 

Operating cash flows from operating leases

 

$

15,497

 

 

$

10,022

 

 

$

951

 

Operating cash flows from finance leases

 

 

2

 

 

 

629

 

 

 

1,896

 

Financing cash flows from finance leases

 

 

135

 

 

 

5,489

 

 

 

12,620

 

Non-cash: Right-of-use assets obtained in exchange for new lease liabilities:

 

 

 

 

 

 

 

 

 

Finance leases

 

 

261

 

 

 

450

 

 

 

662

 

Operating leases

 

 

1,704

 

 

 

3,585

 

 

 

1,072

 

Non-cash: Increase (decrease) resulting from lease modification:

 

 

 

 

 

 

 

 

 

Finance lease right-of-use assets

 

 

 

 

 

(24,654

)

 

 

 

Operating lease right-of-use assets

 

 

 

 

 

93,222

 

 

 

 

Finance lease liabilities, current

 

 

 

 

 

(12,587

)

 

 

 

Operating lease liabilities, current

 

 

 

 

 

9,221

 

 

 

 

Finance lease liabilities, non-current

 

 

 

 

 

(20,009

)

 

 

 

Operating lease liabilities, non-current

 

$

 

 

$

91,943

 

 

$

 

Lease term and discount rate were as follows:

 

 

 

December 31,

 

 

 

2022

 

 

2021

 

Weighted-average remaining lease term (years):

 

 

 

 

 

 

Finance leases

 

 

4.9

 

 

 

1.1

 

Operating leases

 

 

5.8

 

 

 

6.8

 

Weighted-average discount rate:

 

 

 

 

 

 

Finance leases

 

 

6.20

%

 

 

4.64

%

Operating leases

 

 

4.75

%

 

 

4.75

%

Maturities of lease liabilities as of December 31, 2022 are as follows (in thousands):

 

Year Ending December 31,

 

Finance Leases

 

 

Operating Leases

 

2023

 

$

44

 

 

$

13,915

 

2024

 

 

41

 

 

 

17,302

 

2025

 

 

40

 

 

 

18,448

 

2026

 

 

39

 

 

 

18,000

 

2027

 

 

36

 

 

 

18,476

 

Beyond 2027

 

 

 

 

 

17,400

 

Total future lease payments

 

 

200

 

 

 

103,541

 

Less: Interest

 

 

(27

)

 

 

(13,656

)

Present value of lease liabilities

 

$

173

 

 

$

89,885